Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| S-Trityl-L-Cysteine SCHEMBL768202 | 1.00 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL6891349 | 1.00 | KIF11 (0.85) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190175 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL11190178 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL655694 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| S-Trityl-L-Cysteine SCHEMBL655692 | 0.98 | KIF11 (0.82) | KIF11DNMT1 | |
| SCHEMBL12851543 | 0.91 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL14537506 | 0.89 | KIF11 (1.00) | KIF11DNMT1 | |
| SCHEMBL2838308 | 0.88 | KIF11 (0.68) | KIF11DNMT1 | |
| SCHEMBL7753308 | 0.88 | KIF11 (0.68) | KIF11DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 719 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591944-B | High-sensitivity HPV virus detection kit | 杭州康大晨星医学科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119350450-A | Water-based synthesis method of mu-conotoxin KIIIA with instant wrinkle removal effect | 润辉生物技术（威海）有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119080882-A | Eptifibatide derivative and preparation method thereof | 山西医科大学 | 2024-12-06 | — | — | CN | claimed |
| US-12129277-B2 | Linear solution phase routes for WNT hexapeptides | WNTRESEARCH AB (SE) | 2024-10-29 | — | — | US | claimed |
| US-20240342179-A1 | TREATMENT OF CANCERS OR NEOPLASMS BY INHIBITING KIF15 | UNIVERSITY OF KANSAS | 2024-10-17 | — | — | US | claimed |
| CN-118261821-B | Infrared image acquisition and early warning system for animal epidemic disease monitoring | 大连华璟科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118388598-A | Labeling precursor, probe, preparation method and application thereof | 苏州大学附属第一医院 | 2024-07-26 | — | — | CN | claimed |
| WO-2024140687-A1 | S1PR2 REGULATOR AND USE THEREOF | 北京昌平实验室 | 2024-07-04 | — | — | WO | claimed |
| CN-118261821-A | Infrared image acquisition and early warning system for animal epidemic disease monitoring | 大连华璟科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118255830-A | S1PR2 modulators and uses thereof | 北京昌平实验室 | 2024-06-28 | — | — | CN | claimed |
| CN-114629765-A | Space modulation method based on space-time line code and antenna offset | 电子科技大学 | 2022-06-14 | — | — | CN | claimed |
| US-20220098155-A1 | NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) | 2022-03-31 | — | — | US | claimed |
| CN-109134325-A | A kind of S-(trityl)-L-cysteine preparation method | 成都市科隆化学品有限公司 | 2019-01-04 | — | — | CN | claimed |
| WO-2016089208-A2 | SULFONAMIDE, SULFAMATE AND SULFAMIDE DERIVATIVES OF ANTI-CANCER AGENTS | STICHTING MAASTRICHT RADIATION ONCOLOGY "MAASTRO-CLINIC" (NL) | 2016-06-09 | — | — | WO | claimed |
| US-20070111314-A1 | Methods for tagging and authenticating inks using compositions | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2007-05-17 | — | — | US | claimed |
| EP-0751765-A4 | SULFONAMIDE DERIVATIVES AND THEIR USE | PHARMACOPEIA INC (US) | 1997-05-28 | — | — | EP | claimed |
| US-5618825-A | ENZYME INHIBITORS; ANTICOAGULANTS; VISION DISORDERS | PHARMACOPEIA, INC. (US) | 1997-04-08 | — | — | US | claimed |
| EP-0751765-A1 | SULFONAMIDE DERIVATIVES AND THEIR USE | PHARMACOPEIA, INC. (US) | 1997-01-08 | — | — | EP | claimed |
| WO-1995024186-A1 | SULFONAMIDE DERIVATIVES AND THEIR USE | PHARMACOPEIA, INC. (US) | 1995-09-14 | — | — | WO | claimed |
| US-3976781-A | SULFUR CONTAINING AMINES | L'OREAL (FR) | 1976-08-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220098155-A1 | NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 | SSTR5, SLC6A15, SLC1A5 | KIF11 3071/4885DNMT1 2054/4885 |
| US-20240342179-A1 | TREATMENT OF CANCERS OR NEOPLASMS BY INHIBITING KIF15 | KIF15, KIF11, KIF2C | KIF11 2/4885DNMT1 3403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.